Genetic Testing
23andMe, Once Worth $6 Billion, Files for Bankruptcy
CEO Anne Wojcicki resigned on Sunday, though she says she'll independently bid for ownership of the company she co-founded.
Powering Genomics and Genetic Testing
Genome testing offers us a peak into a scientific future
Meet Color Genomics, the Startup That Wants to Make Genetic Testing Less Expensive
The Silicon Valley startup just raised $15 million in funding from PayPal co-founder Max Levchin, Yahoo's Jerry Yang and other high-profile investors.
FDA Grants 23andMe Approval to Sell Test for Rare Genetic Condition
It's a small but definite step towards 23andMe's goal of selling DNA kits again.
In Taking Aim at 23andMe, Regulators Missed the Mark
The controversy over genetic-testing company 23andMe begs the question: Is knowledge really that dangerous?
FDA Tells 23andMe to Quit Selling Genetic Testing Kits
The Food and Drug Administration said the popular genetics testing kits are being sold without 'marketing clearance or approval.'